IOVA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Iovance Biotherapeutics Inc (IOVA).


$2.26B Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

IOVA Market Cap. (MRY)


IOVA Shares Outstanding (MRY)


IOVA Assets (MRY)


Total Assets

$910.43M

Total Liabilities

$200.02M

Total Investments

$208.09M

IOVA Income (MRY)


Revenue

$164.07M

Net Income

-$372.18M

Operating Expense

$435.35M

IOVA Cash Flow (MRY)


CF Operations

-$352.98M

CF Investing

-$96.41M

CF Financing

$390.66M

IOVA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IOVA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$910,426,000 (16.67%)

$780,351,000 (17.53%)

$663,982,000 (-14.58%)

$777,333,000 (1.15%)

Assets Current

$457,018,000 (48.46%)

$307,848,000 (-35.75%)

$479,116,000 (-5.68%)

$507,956,000 (-20.15%)

Assets Non-Current

$453,408,000 (-4.04%)

$472,503,000 (155.59%)

$184,866,000 (-31.37%)

$269,377,000 (103.52%)

Goodwill & Intangible Assets

$282,398,000 (23.18%)

$229,258,000 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$710,405,000 (21.52%)

$584,613,000 (17.01%)

$499,638,000 (-19.63%)

$621,659,000 (-5.31%)

Property Plant & Equipment Net

$164,282,000 (-6.95%)

$176,545,000 (-0.95%)

$178,247,000 (4.90%)

$169,921,000 (49.16%)

Cash & Equivalents

$122,053,000 (-32.69%)

$181,318,000 (-23.87%)

$238,161,000 (182.47%)

$84,313,000 (15.73%)

Accumulated Other Comprehensive Income

-$1,046,000 (-141.41%)

$2,526,000 (380.04%)

-$902,000 (-50.08%)

-$601,000 (-3263.16%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$208,087,000 (26.13%)

$164,979,000 (-31.29%)

$240,114,000 (-53.63%)

$517,769,000 (-7.89%)

Investments Current

$208,087,000 (26.13%)

$164,979,000 (-31.29%)

$240,114,000 (-43.66%)

$426,181,000 (-24.18%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$91,588,000 (0%)

Inventory

$51,520,000 (396.72%)

$10,372,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$69,340,000 (45820.53%)

$151,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$27,509,000 (-16.95%)

$33,123,000 (24.51%)

$26,603,000 (-2.83%)

$27,377,000 (102.60%)

Accumulated Retained Earnings (Deficit)

-$2,384,552,000 (-18.49%)

-$2,012,375,000 (-28.31%)

-$1,568,338,000 (-33.77%)

-$1,172,445,000 (-41.23%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$32,315,000 (86.29%)

$17,347,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$58,261,000 (-23.20%)

$75,862,000 (-11.22%)

$85,446,000 (19.45%)

$71,531,000 (38.47%)

Debt Current

$12,896,000 (65.82%)

$7,777,000 (-38.21%)

$12,587,000 (148.90%)

$5,057,000 (-19.53%)

Debt Non-Current

$45,365,000 (-33.37%)

$68,085,000 (-6.55%)

$72,859,000 (9.61%)

$66,474,000 (46.50%)

Total Liabilities

$200,021,000 (2.19%)

$195,738,000 (19.10%)

$164,344,000 (5.57%)

$155,674,000 (39.04%)

Liabilities Current

$122,341,000 (10.91%)

$110,306,000 (20.57%)

$91,485,000 (2.56%)

$89,200,000 (62.56%)

Liabilities Non-Current

$77,680,000 (-9.07%)

$85,432,000 (17.26%)

$72,859,000 (9.61%)

$66,474,000 (16.44%)

IOVA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$164,070,000 (13698.99%)

$1,189,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$123,995,000 (1052.91%)

$10,755,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$153,017,000 (43.12%)

$106,916,000 (2.71%)

$104,097,000 (24.42%)

$83,664,000 (38.95%)

Research & Development Expense

$282,336,000 (-17.94%)

$344,077,000 (16.72%)

$294,781,000 (13.80%)

$259,039,000 (28.41%)

Operating Expenses

$435,353,000 (-3.47%)

$450,993,000 (13.07%)

$398,878,000 (16.39%)

$342,703,000 (30.83%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$2,828,000 (18.71%)

-$3,479,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$372,177,000 (16.18%)

-$444,037,000 (-12.16%)

-$395,893,000 (-15.67%)

-$342,252,000 (-31.85%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$372,177,000 (16.18%)

-$444,037,000 (-12.16%)

-$395,893,000 (-15.67%)

-$342,252,000 (-31.85%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$372,177,000 (16.18%)

-$444,037,000 (-12.16%)

-$395,893,000 (-15.67%)

-$342,252,000 (-31.85%)

Weighted Average Shares

$289,877,000 (23.28%)

$235,131,000 (47.64%)

$159,259,000 (3.82%)

$153,406,000 (10.92%)

Weighted Average Shares Diluted

$289,877,000 (23.28%)

$235,131,000 (47.64%)

$159,259,000 (3.82%)

$153,406,000 (10.92%)

Earning Before Interest & Taxes (EBIT)

-$375,005,000 (16.20%)

-$447,516,000 (-13.04%)

-$395,893,000 (-15.67%)

-$342,252,000 (-31.85%)

Gross Profit

$40,075,000 (518.93%)

-$9,566,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$395,278,000 (14.17%)

-$460,559,000 (-15.46%)

-$398,878,000 (-16.39%)

-$342,703,000 (-30.83%)

IOVA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$96,411,000 (37.90%)

-$155,242,000 (-160.53%)

$256,455,000 (194184.09%)

$132,000 (100.04%)

Net Cash Flow from Financing

$390,664,000 (-15.62%)

$462,959,000 (143.47%)

$190,150,000 (-20.53%)

$239,268,000 (-58.49%)

Net Cash Flow from Operations

-$352,977,000 (2.44%)

-$361,820,000 (-23.59%)

-$292,757,000 (-28.44%)

-$227,941,000 (-11.12%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$59,265,000 (-4.26%)

-$56,843,000 (-136.95%)

$153,848,000 (1242.60%)

$11,459,000 (-78.56%)

Net Cash Flow - Business Acquisitions and Disposals

-$52,573,000 (75.28%)

-$212,633,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$32,769,000 (-141.13%)

$79,681,000 (-71.22%)

$276,880,000 (634.31%)

$37,706,000 (113.91%)

Capital Expenditure

-$11,069,000 (50.34%)

-$22,290,000 (-9.13%)

-$20,425,000 (45.64%)

-$37,574,000 (19.70%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$1,000,000 (0%)

Issuance (Purchase) of Equity Shares

$403,522,000 (-13.36%)

$465,754,000 (141.57%)

$192,799,000 (-19.08%)

$238,268,000 (-58.68%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$541,000 (80.26%)

-$2,740,000 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$109,627,000 (75.05%)

$62,625,000 (-25.47%)

$84,022,000 (20.44%)

$69,765,000 (70.63%)

Depreciation Amortization & Accretion

$43,606,000 (31.63%)

$33,127,000 (56.74%)

$21,135,000 (51.18%)

$13,980,000 (60.47%)

IOVA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

24.40% (103.03%)

-804.50%

-

-

Profit Margin

-226.80% (99.39%)

-37345.40%

-

-

EBITDA Margin

-202.00% (99.42%)

-34851.90%

-

-

Return on Average Equity (ROAE)

-50.80% (28.35%)

-70.90% (14.16%)

-82.60% (-63.56%)

-50.50% (-15.30%)

Return on Average Assets (ROAA)

-39.90% (27.85%)

-55.30% (11.94%)

-62.80% (-47.07%)

-42.70% (-9.21%)

Return on Sales (ROS)

-228.60% (99.39%)

-37638.00%

-

-

Return on Invested Capital (ROIC)

-84.50% (47.78%)

-161.80% (-100.25%)

-80.80% (-66.26%)

-48.60% (-0.83%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-5.78 (-34.38%)

-4.3 (-67.65%)

-2.57 (70.03%)

-8.56 (65.31%)

Price to Sales Ratio (P/S)

13.07 (-99.19%)

1,607.75

-

-

Price to Book Ratio (P/B)

3.17 (-10.79%)

3.56 (76.28%)

2.02 (-58.09%)

4.82 (-53.53%)

Debt to Equity Ratio (D/E)

0.28 (-15.82%)

0.34 (1.82%)

0.33 (31.60%)

0.25 (46.20%)

Earnings Per Share (EPS)

-1.28 (32.28%)

-1.89 (24.10%)

-2.49 (-11.66%)

-2.23 (-18.62%)

Sales Per Share (SPS)

0.57 (11220.00%)

0.01 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.26 (23.13%)

-1.63 (16.89%)

-1.97 (-13.58%)

-1.73 (4.99%)

Book Value Per Share (BVPS)

2.45 (-1.41%)

2.49 (-20.75%)

3.14 (-22.58%)

4.05 (-14.64%)

Tangible Assets Book Value Per Share (TABVPS)

2.17 (-7.55%)

2.34 (-43.78%)

4.17 (-17.72%)

5.07 (-8.80%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (-50.00%)

-4 (-100.00%)

-2 (77.78%)

-9 (65.38%)

Enterprise Value Over EBITDA (EV/EBITDA)

-6.53 (-48.18%)

-4.41 (-71.31%)

-2.57 (71.88%)

-9.15 (65.97%)

Asset Turnover

0.18 (17500.00%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.74 (33.86%)

2.79 (-46.71%)

5.24 (-8.04%)

5.7 (-50.88%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$364,046,000 (5.22%)

-$384,110,000 (-22.65%)

-$313,182,000 (-17.95%)

-$265,515,000 (-5.39%)

Enterprise Value (EV)

$2,163,776,846 (18.50%)

$1,825,943,982 (89.43%)

$963,919,313 (-67.90%)

$3,002,875,163 (-55.47%)

Earnings Before Tax (EBT)

-$375,005,000 (16.20%)

-$447,516,000 (-13.04%)

-$395,893,000 (-15.67%)

-$342,252,000 (-31.85%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$331,399,000 (20.03%)

-$414,389,000 (-10.58%)

-$374,758,000 (-14.16%)

-$328,272,000 (-30.85%)

Invested Capital

$441,895,000 (31.78%)

$335,331,000 (-20.12%)

$419,782,000 (-37.84%)

$675,351,000 (-2.46%)

Working Capital

$334,677,000 (69.42%)

$197,542,000 (-49.04%)

$387,631,000 (-7.43%)

$418,756,000 (-27.95%)

Tangible Asset Value

$628,028,000 (13.96%)

$551,093,000 (-17.00%)

$663,982,000 (-14.58%)

$777,333,000 (1.15%)

Market Capitalization

$2,255,377,846 (8.40%)

$2,080,616,982 (106.29%)

$1,008,601,313 (-66.33%)

$2,995,204,163 (-55.99%)

Average Equity

$733,106,000 (17.11%)

$626,017,750 (30.55%)

$479,514,000 (-29.27%)

$677,958,250 (14.43%)

Average Assets

$933,923,250 (16.21%)

$803,681,500 (27.47%)

$630,508,750 (-21.42%)

$802,380,250 (20.81%)

Invested Capital Average

$443,684,000 (60.37%)

$276,655,500 (-43.54%)

$490,016,250 (-30.35%)

$703,559,000 (30.77%)

Shares

304,780,790 (19.09%)

255,918,448 (62.14%)

157,840,581 (0.60%)

156,899,118 (6.96%)